期刊文献+

糖尿病并发急性心肌梗死的研究进展 被引量:6

下载PDF
导出
摘要 1发病机制 冠状动脉粥样硬化是糖尿病合并心肌梗死(AMI)的基本病因。糖尿病导致冠状动脉粥样硬化的可能机制中,血脂异常扮演着最重要的角色。脂代谢紊乱可以引起血液处于高凝状态、内皮功能和血小板功能异常以及阿司匹林抵抗和微循环及侧支循环形成障碍等。
作者 胡沛 马莉
出处 《实用临床医药杂志》 CAS 2017年第1期205-208,共4页 Journal of Clinical Medicine in Practice
  • 相关文献

参考文献1

二级参考文献23

  • 1Holmes DR,Leon MB,Moses JW,Popma JJ,Cutlip D,Fitzgerald P J,et al.Analysis of l-year clinical outcomes in the SIRIUS trial:a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.Circulation 2004; 109:634-640.
  • 2Sabate M,Jimenez-Quevedo E Angiolillo D J,Gomez-Hospital JA,Alfonso E Hernandez-Antolin R,et al.Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients:the diabetes and sirolimus-eluting stem (DIABETES) trial.Circulation 2005; 112:2175-2183.
  • 3Schofer J,Schluter M,Gershlick AH,Wijns W,Garcia E,Schampaert E,et al.Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries:double-blind,randomised controlled trial (E-SIRIUS).Lancet 2003; 362:1093-1099.
  • 4Stone GW,Ellis SG,Cox DA,Hermiller J,O'Shaughnessy C,Mann JT,et al.One-year clinical results with the slow-release,polymer-based,paclitaxel-eluting TAXUS stent:the TAXUS-IV trial.Circulation 2004; 109:1942-1947.
  • 5Moreno R,Fernandez C,Hemandez R,Alfonso E Angiolillo DJ,Sabate M,et al.Drug-eluting stent thrombosis:results from a pooled analysis including 10 randomized studies.J Am Coll Cardiol 2005; 45:954-959.
  • 6Fuchs AT,Kuehnl A,Pelisek J,Rolland PH,Mekkaoui C,Netz H,et al.Meta-analysis shows similar risk of thrombosis after drug-eluting stent,bare-metal stent,or angioplasty.Endothelium 2008; 15:93-100.
  • 7Antman EM,Hand M,Armstrong PW,Bates ER,Green LA,Halasyamani LK,et al.2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction:a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines:developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians:2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients with ST-Elevation Myocardial Infarction,Writing on Behalf of the 2004 Writing Committee.Circulation 2008; 117:296-329.
  • 8King SB,3rd,Smith SC,Jr.,Hirshfeld JW,Jr.,Jacobs AK,Morrison DA,Williams DO,et al.2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention:a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines.J Am Coil Cardiol 2008; 51:172-209.
  • 9Little WC,Applegate RJ.Coronary angiography before myocardial infarction:can the culprit site be prospectively recognized? Am Heart J 1998; 136:368-370.
  • 10Okayama S,Uemura S,Nishida T,Morikawa Y,Onoue K,Takemoto Y,et al.Progression of non-culprit coronary artery atherosclerosis after acute myocardial infarction in comparison with stable angina pectoris.J Atheroscler Thromb 2008; 15:228-234.

共引文献3

同被引文献48

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部